Stock Research: Metropolis Healthcare

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Metropolis Healthcare

NSI:METROPOLIS INE112L01020
52
  • Value
    19
  • Growth
    73
  • Safety
    Safety
    55
  • Combined
    49
  • Sentiment
    48
  • 360° View
    360° View
    52
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Metropolis Healthcare Limited is an India-based company providing diagnostic services to patients, healthcare providers, and corporates. It operates in the pathology service industry, specializing in various pathological investigations including biochemistry, hematology, and microbiology, serving both B2B and B2C markets with over 4,000 tests. The company operates across India and Africa, with approximately 200 clinical laboratories and 4,300 service centers in 22 Indian states. In the last fiscal year, the company had a market cap of $1193 million, profits of $123 million, and revenue of $156 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
19 23 12 5
Growth
73 59 55 97
Safety
Safety
55 46 41 73
Sentiment
48 25 27 18
360° View
360° View
52 20 12 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
59 46 13 33
Opinions Change
54 8 50 37
Pro Holdings
n/a 12 56 47
Market Pulse
25 82 54 41
Sentiment
48 25 27 18
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
19 23 12 5
Growth
73 59 55 97
Safety Safety
55 46 41 73
Combined
49 25 19 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
15 28 19 5
Price vs. Earnings (P/E)
19 26 10 3
Price vs. Book (P/B)
13 16 19 5
Dividend Yield
45 28 39 46
Value
19 23 12 5
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
86 88 74 74
Profit Growth
89 55 24 60
Capital Growth
10 50 59 100
Stock Returns
69 43 55 85
Growth
73 59 55 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
60 54 52 70
Refinancing
29 19 17 33
Liquidity
55 60 56 75
Safety Safety
55 46 41 73

Similar Stocks

Discover high‑ranked alternatives to Metropolis Healthcare and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Medium
Full Stock Analysis

Canara Bank

NSI:CANBK
Country: India
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Diagnósticos da América

SAO:DASA3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Oil and Natural Gas

NSI:ONGC
Country: India
Industry: Oil & Gas Integrated
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

The only positive is high growth. The stock is expensive (low Value Rank), risky to finance, and carries critical professional sentiment. This is a risky proposition. Avoid unless you have exceptional conviction that the growth alone will overcome the price and financial risks.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: